Who leads our work

MD, MPH, MSc Clinical Epidemiology
Founder & Principal Consultant

Dr Ibrahima Diallo is a physician, public health specialist and epidemiologist with over 20 years of international experience across public health, epidemiological and clinical research, monitoring and evaluation, digital health and health information systems.

He trained in medicine at the University of Conakry, community health at the University of Geneva, public health at Paris-Saclay University, and clinical epidemiology at Toulouse III University.

His career combines clinical and research experience with the design and management of health programmes, coordination of multicountry clinical studies, monitoring and evaluation, and the development and implementation of health information systems. He has worked at country, regional and global levels for the United Nations Refugee Agency, Médecins Sans Frontières, Terre des hommes, and international research institutions.

Based in Fribourg, Switzerland, he works in French and English.

Peer-reviewed research spanning population-based epidemiology, clinical research and multicountry clinical trials, with a particular focus on Africa. These publications reflect the scientific and analytical foundation that informs our approach to research, evidence generation and public health advisory work.

The first population-based survey of its kind in the province. A cluster sample of 1,537 adults aged 35 and above, drawn from urban Labé and rural Fellö Koundoua, found crude diabetes prevalence of 6.1% and impaired fasting glucose of 13.4%. The findings contributed to the development of Guinea’s national response programme on non-communicable diseases, and the study is still cited in West African NCD literature and in International Diabetes Federation regional estimates.

The 2LADY trial (ANRS 12169 / EDCTP), in which Dr Diallo served as a member of the study group and coordinated research activities across sites. A 48-week randomised, open-label, non-inferiority trial across Bobo-Dioulasso, Yaoundé and Dakar; of 454 patients randomised, 451 were analysed. All three regimens achieved similar virological control, confirming the WHO-recommended combination as a valid option for African treatment programmes.

A companion analysis from the same 1,537-participant cohort, examining hypertension prevalence and associated metabolic abnormalities across rural and urban settings. The rural–urban contrast provided early evidence on the role of urbanisation in cardiovascular risk in Guinea.

Conducted at INSERM U558, Toulouse. A population-based study reconciling cancer registry records with medical documentation across five departments, analysing how diagnosis circumstances, stage distribution and clinical management shifted over the period in which PSA testing entered routine practice.

Conference contributions to AFRAVIH (Montpellier 2014, Geneva 2012), the EDCTP Forum (Addis Ababa 2011) and ALFEDIAM (Nice 2004), covering second-line ART treatment failure detection, informed consent methodology in multi-site trials, and diabetes prevalence in Guinea.

Produced in an institutional capacity and remaining the property of the commissioning organisations: mortality surveillance guidance, health access and utilisation survey guidance, case definitions, a standard public health indicators guide, six chapters of an emergency toolkit, and a blended training course on public health in refugee emergencies.